Business Description
Grifols SA
NAICS : 325412
ISIN : US3984384087
Share Class Description:
GRFS: ADRDescription
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.08 | |||||
| Equity-to-Asset | 0.26 | |||||
| Debt-to-Equity | 1.99 | |||||
| Debt-to-EBITDA | 10.49 | |||||
| Interest Coverage | 1.66 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.98 | |||||
| Beneish M-Score | -2.1 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.6 | |||||
| 3-Year EBITDA Growth Rate | -5.7 | |||||
| 3-Year EPS without NRI Growth Rate | -45 | |||||
| 3-Year Book Growth Rate | 4.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 39.76 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.13 | |||||
| 9-Day RSI | 49.61 | |||||
| 14-Day RSI | 47.25 | |||||
| 6-1 Month Momentum % | 24.29 | |||||
| 12-1 Month Momentum % | -16.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.26 | |||||
| Quick Ratio | 0.79 | |||||
| Cash Ratio | 0.34 | |||||
| Days Inventory | 390.12 | |||||
| Days Sales Outstanding | 54.92 | |||||
| Days Payable | 94.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.3 | |||||
| Shareholder Yield % | 3.53 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 39.03 | |||||
| Operating Margin % | 15.16 | |||||
| Net Margin % | 2.6 | |||||
| FCF Margin % | -1.62 | |||||
| ROE % | 2.45 | |||||
| ROA % | 0.65 | |||||
| ROIC % | 2.68 | |||||
| ROC (Joel Greenblatt) % | 11.68 | |||||
| ROCE % | 4.25 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 45.11 | |||||
| Forward PE Ratio | 8.41 | |||||
| PE Ratio without NRI | 42.8 | |||||
| Shiller PE Ratio | 11.26 | |||||
| PS Ratio | 1.2 | |||||
| PB Ratio | 1.17 | |||||
| Price-to-Operating-Cash-Flow | 30.07 | |||||
| EV-to-EBIT | 20.93 | |||||
| EV-to-Forward-EBIT | 13.53 | |||||
| EV-to-EBITDA | 16.52 | |||||
| EV-to-Forward-EBITDA | 9.3 | |||||
| EV-to-Revenue | 3.11 | |||||
| EV-to-Forward-Revenue | 1.9 | |||||
| EV-to-FCF | -192.3 | |||||
| Price-to-Projected-FCF | 0.9 | |||||
| Price-to-Median-PS-Value | 0.34 | |||||
| Earnings Yield (Greenblatt) % | 4.78 | |||||
| FCF Yield % | -1.53 | |||||
| Forward Rate of Return (Yacktman) % | -9.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GRFS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Grifols SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 5,876.521 | ||
| EPS (TTM) ($) | 0.224 | ||
| Beta | 0.69 | ||
| Volatility % | 58.23 | ||
| 14-Day RSI | 47.25 | ||
| 14-Day ATR ($) | 0.399399 | ||
| 20-Day SMA ($) | 7.5775 | ||
| 12-1 Month Momentum % | -16.18 | ||
| 52-Week Range ($) | 5.3001 - 12.1499 | ||
| Shares Outstanding (Mil) | 679.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Grifols SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Grifols SA Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Grifols SA Frequently Asked Questions
What is Grifols SA(GRFS)'s stock price today?
The current price of GRFS is $7.74. The 52 week high of GRFS is $12.15 and 52 week low is $5.30.
When is next earnings date of Grifols SA(GRFS)?
The next earnings date of Grifols SA(GRFS) is 2025-02-28 Est..
Does Grifols SA(GRFS) pay dividends? If so, how much?
Grifols SA(GRFS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers